vs
Side-by-side financial comparison of INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM) and Kymera Therapeutics, Inc. (KYMR). Click either name above to swap in a different company.
Kymera Therapeutics, Inc. is the larger business by last-quarter revenue ($11.5M vs $6.1M, roughly 1.9× INTELLIGENT PROTECTION MANAGEMENT CORP.). On growth, INTELLIGENT PROTECTION MANAGEMENT CORP. posted the faster year-over-year revenue change (2091.6% vs -55.3%). Over the past eight quarters, INTELLIGENT PROTECTION MANAGEMENT CORP.'s revenue compounded faster (54.7% CAGR vs 10.1%).
Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.
Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.
IPM vs KYMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $11.5M |
| Net Profit | — | $-76.6M |
| Gross Margin | 53.1% | — |
| Operating Margin | -13.4% | -736.8% |
| Net Margin | — | -667.6% |
| Revenue YoY | 2091.6% | -55.3% |
| Net Profit YoY | — | -82.1% |
| EPS (diluted) | $-0.05 | $-0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $5.7M | $11.5M | ||
| Q1 25 | $5.5M | $22.1M | ||
| Q4 24 | — | $7.4M | ||
| Q2 24 | — | $25.6M | ||
| Q1 24 | — | $10.3M | ||
| Q4 23 | $-7.3M | $47.9M |
| Q4 25 | — | — | ||
| Q3 25 | $-1.1M | — | ||
| Q2 25 | $-1.1M | $-76.6M | ||
| Q1 25 | $808.5K | $-65.6M | ||
| Q4 24 | — | $-70.8M | ||
| Q2 24 | — | $-42.1M | ||
| Q1 24 | — | $-48.6M | ||
| Q4 23 | — | $-14.4M |
| Q4 25 | 53.1% | — | ||
| Q3 25 | 50.7% | — | ||
| Q2 25 | 50.1% | — | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | -13.4% | — | ||
| Q3 25 | -23.0% | — | ||
| Q2 25 | -19.7% | -736.8% | ||
| Q1 25 | -24.2% | -336.8% | ||
| Q4 24 | — | -1092.2% | ||
| Q2 24 | — | -198.5% | ||
| Q1 24 | — | -562.2% | ||
| Q4 23 | — | -40.3% |
| Q4 25 | — | — | ||
| Q3 25 | -17.4% | — | ||
| Q2 25 | -18.3% | -667.6% | ||
| Q1 25 | 14.7% | -296.7% | ||
| Q4 24 | — | -956.9% | ||
| Q2 24 | — | -164.0% | ||
| Q1 24 | — | -472.0% | ||
| Q4 23 | — | -30.0% |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.08 | — | ||
| Q2 25 | $-0.08 | $-0.95 | ||
| Q1 25 | $0.06 | $-0.82 | ||
| Q4 24 | — | $-0.89 | ||
| Q2 24 | — | $-0.58 | ||
| Q1 24 | — | $-0.69 | ||
| Q4 23 | $-0.03 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $335.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.2M | $971.5M |
| Total Assets | $26.0M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | — | ||
| Q3 25 | $7.3M | — | ||
| Q2 25 | $7.3M | $335.8M | ||
| Q1 25 | $9.7M | $90.0M | ||
| Q4 24 | — | $120.3M | ||
| Q2 24 | — | $67.6M | ||
| Q1 24 | — | $93.5M | ||
| Q4 23 | $13.6M | $110.0M |
| Q4 25 | $18.2M | — | ||
| Q3 25 | $18.8M | — | ||
| Q2 25 | $19.9M | $971.5M | ||
| Q1 25 | $21.1M | $786.2M | ||
| Q4 24 | — | $835.6M | ||
| Q2 24 | — | $684.9M | ||
| Q1 24 | — | $711.2M | ||
| Q4 23 | $20.1M | $395.0M |
| Q4 25 | $26.0M | — | ||
| Q3 25 | $27.2M | — | ||
| Q2 25 | $29.8M | $1.1B | ||
| Q1 25 | $31.1M | $918.3M | ||
| Q4 24 | — | $978.0M | ||
| Q2 24 | — | $826.0M | ||
| Q1 24 | — | $868.3M | ||
| Q4 23 | $23.9M | $575.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.6K | $-59.9M |
| Free Cash FlowOCF − Capex | — | $-60.6M |
| FCF MarginFCF / Revenue | — | -527.9% |
| Capex IntensityCapex / Revenue | — | 6.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-250.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6K | — | ||
| Q3 25 | $133.0K | — | ||
| Q2 25 | $-888.7K | $-59.9M | ||
| Q1 25 | $1.7M | $-79.2M | ||
| Q4 24 | — | $-61.8M | ||
| Q2 24 | — | $-42.9M | ||
| Q1 24 | — | $-39.6M | ||
| Q4 23 | $-99.0K | $8.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-60.6M | ||
| Q1 25 | — | $-79.6M | ||
| Q4 24 | — | $-62.7M | ||
| Q2 24 | — | $-47.6M | ||
| Q1 24 | — | $-47.0M | ||
| Q4 23 | — | $-3.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -527.9% | ||
| Q1 25 | — | -360.3% | ||
| Q4 24 | — | -848.3% | ||
| Q2 24 | — | -185.7% | ||
| Q1 24 | — | -456.8% | ||
| Q4 23 | — | -7.5% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 12.7% | ||
| Q2 24 | — | 18.3% | ||
| Q1 24 | — | 72.0% | ||
| Q4 23 | — | 24.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
KYMR
Segment breakdown not available.
